SHEN Xiao-zhong1, YANG Fan3, YU Rong-min2. Optimization of Extration Technology for Astragaloside Ⅳ from Asrtagalus membranacevs by Response Surface Methodology[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(18): 34-37.
SHEN Xiao-zhong1, YANG Fan3, YU Rong-min2. Optimization of Extration Technology for Astragaloside Ⅳ from Asrtagalus membranacevs by Response Surface Methodology[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(18): 34-37. DOI: 10.13422/j.cnki.syfjx.2012.18.028.
Optimization of Extration Technology for Astragaloside Ⅳ from Asrtagalus membranacevs by Response Surface Methodology
摘要
目的:响应面法优选黄芪的渗漉提取工艺。方法:采用三因素三水平Box-Behnken试验设计
以乙醇体积分数、流速、乙醇用量为自变量
黄芪甲苷提取率为因变量
HPLC-ELSD测定黄芪甲苷含量
通过对自变量各水平的多元回归及二项式拟合
用响应面法优选乙醇渗漉提取工艺
并进行预测分析。结果:最佳提取工艺条件为30%乙醇
流速1.9 mL.min-1.cm-2
乙醇用量为药材量6.5倍。在此条件下
黄芪甲苷提取率理论值1.50 mg.g-1
实测值1.487 mg.g-1
说明该优选工艺模型拟合度良好。结论:Box-Behnken试验设计可用于黄芪渗漉提取工艺的优选
该优选工艺简便、稳定。
Abstract
Objective:To optimize extraction technology of astragaloside Ⅳ from Astragalus membranaceus by response surface methodology(RSM).Method:Three-factor and three-level Box-Behnken experimental design was employed with ethanol concentration
flow rate and liquid-solid ratioas independence variables
extraction rate of astragaloside Ⅳ as dependent variable which was determined by HPLC-ELSD
experimental data obtained by multiple regression and binomial fitting of levels from independent variables
ethanol percocation extraction technology was optimized by RSM
and to predictive analysis.Result:Optimum extraction conditions were as follows:30% ethanol as solvent
flow rate 1.9 mL · min-1 · cm-2
liquid-solid ratio 6.5 mL · g-1.Under these conditions
theoretical value of extraction rate of astragaloside Ⅳ 1.50 mg · g-1
but measured value of 1.487 mg · g-1
it showed optimized technology model fitted well.Conclusion:Box-Behnken experimental design could be used for extraction optimization of percocation extraction process for A.membranaceus
Optimization of Extration Technology for Astragaloside Ⅳ from by Response Surface Methodology
Analysis of Mechanism of Astragaloside Ⅳ in Regulating Ferroptosis Through SLC7A11/GPX4 Pathway Against Vascular Smooth Muscle Cell Proliferation
Mechanism of Astragaloside Ⅳ in Regulating PI3K/Akt Molecular Pathway in Prevention and Treatment of Diabetes Complications: A Review
Molecular Mechanism of Action of Astragaloside Ⅳ in Modulating Pyroptosis to Attenuate Intestinal Ischemia-reperfusion Injury Based on Experimental Validation
Optimization of Decoction Technology and Establishment of Quality Standard for Moringaoleifera Leaf Standard Decoction
Related Author
SHEN Xiao-zhong
YANG Fan
YU Rong-min
LI Guoting
YANG Changchao
LIU Lin
LI Weikang
ZHAO Zixian
Related Institution
Hebei Key Laboratory of Traditional Chinese Medicine(TCM) Research on Cardiocerebrovascular Disease,TCM Processing Technology Innovation Center of Hebei Province,College of Pharmacy, Hebei University of Chinese Medicine
Key Laboratory of Xin'an Medical Education Department,Anhui University of Chinese Medicine
The First Affiliated Hospital of Anhui University of Chinese Medicine